Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women (Q37480990)

20 August 2017

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women (English)

1 reference

20 August 2017

1 reference

1 reference

12

Jean Wactawski-Wende

1 reference

20 August 2017

Garnet L Anderson

2

0 references

Lewis Kuller

series ordinal

6

object named as

Lewis H Kuller

1 reference

20 August 2017

7

JoAnn E Manson

1 reference

20 August 2017

8

Marcia L Stefanick

1 reference

20 August 2017

9

Judith Ockene

1 reference

20 August 2017

1

Rowan T Chlebowski

1 reference

20 August 2017

15

Susan L Hendrix

1 reference

20 August 2017

4

Dorothy S Lane

1 reference

20 August 2017

3

Margery Gass

1 reference

20 August 2017

10

Gloria E Sarto

1 reference

20 August 2017

17

Thomas E Rohan

1 reference

20 August 2017

5

Aaron K Aragaki

1 reference

20 August 2017

18

Shagufta Yasmeen

1 reference

20 August 2017

20

WHI Investigators

1 reference

20 August 2017

13

Peter M Ravdin

1 reference

20 August 2017

14

Robert Schenken

1 reference

20 August 2017

16

Aleksandar Rajkovic

1 reference

20 August 2017

Karen C Johnson

11

1 reference

PMCID

5142300

20 August 2017

Ross L Prentice

series ordinal

19

1 reference

PMCID

5142300

20 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

The Journal of the American Medical Association

20 August 2017

1 reference

20 August 2017

304

1 reference

20 August 2017

1684-1692

1 reference

20 August 2017

15

1 reference

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Coronary heart disease and menopause management: the swinging pendulum of HRT.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Breast cancer after use of estrogen plus progestin in postmenopausal women

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experience

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Prediagnostic use of hormone therapy and mortality after breast cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

The decrease in breast-cancer incidence in 2003 in the United States

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

The Women's Health Initiative recruitment methods and results

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Breast cancer and hormone-replacement therapy in the Million Women Study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Estrogen and angiogenesis: A review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Improved breast cancer survival among hormone replacement therapy users is durable after 5 years of additional follow-up

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142300

Outcomes ascertainment and adjudication methods in the women's health initiative

2 September 2018

1 reference

12 December 2020

Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

1 reference

12 December 2020

Implementation of the women's health initiative study design

1 reference

12 December 2020

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy

1 reference

12 December 2020

Progestin regulation of vascular endothelial growth factor in human breast cancer cells

1 reference

12 December 2020

[The role of estrogens in angiogenesis in the female reproductive system]

1 reference

12 December 2020

Postmenopausal Hormone Use, Screening, and Breast Cancer: Characterization and Control of a Bias

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.2010.1500

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

PMCID

5142300